NYSE$NUS
Nu Skin Enterprises Inc · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
Nu Skin Enterprises reported fourth quarter and full-year 2024 results above company revenue guidance, with sequential revenue growth and adjusted earnings exceeding expectations due to restructuring plan completion.
Nu Skin Enterprises exceeded its latest revenue guidance for both the fourth quarter and full-year 2024, driven by sequential revenue growth and the material completion of its restructuring plan. The company reported a fourth-quarter revenue of $445.6 million and an adjusted EPS of $0.38, while full-year revenue reached $1.73 billion with an adjusted EPS of $0.84.
- Nu Skin's Q4 2024 revenue of $445.6 million exceeded guidance, despite an 8.8% year-over-year decrease.
- Adjusted EPS for Q4 2024 was $0.38, surpassing expectations due to the completion of the restructuring plan.
- Full-year 2024 revenue was $1.73 billion, a 12.0% decrease from 2023, with Rhyz revenue growing by 32.3%.
- The company anticipates improving business trends and a return to year-over-year growth in several markets in 2025, despite continued economic challenges.
Headline financials
Revenue & EPS history
Nu Skin · Revenue · Quarterly
$446M
Revenue by segment
Nu Skin · $449M total across 2 segments · Q3 2023
- Total Nu Skin$438M—97.6%
- Rhyz Other$10.8M+1909.9%2.4%
Forward guidance
Nu Skin anticipates improving business trends and a return to year-over-year growth in several markets in 2025, with a focus on strengthening its core business and rolling out enhanced sales performance compensation plans. The company projects Q1 2025 revenue between $345 million and $365 million, and full-year 2025 revenue between $1.48 billion and $1.62 billion.
Tailwinds
- Anticipates improving business trends and a return to year-over-year growth in several markets in 2025.
- Focus on strengthening core Nu Skin business with continued rollout of enhanced sales performance compensation plan.
- Accelerating growth in developing markets, including Latin America.
- Introduction of Prysm iO™, an exclusive intelligent wellness device, expected to infuse energy and future growth for the nutrition business.
- Strategic transaction of Mavely for $250 million strengthened the balance sheet and underscored Rhyz's value.
Headwinds
- Anticipates continued economic challenges and poor consumer sentiment, particularly in Greater China and South Korea.
- Q1 2025 revenue projected to be lower than Q4 2024 due to seasonality.
- Approximately 3% foreign currency headwind anticipated for Q1 and FY 2025 revenue.
- Excluding the gain from the Mavely transaction, adjusted EPS for Q1 2025 is projected to be $0.10 to $0.20.
- Excluding the gain from the Mavely transaction, adjusted EPS for FY 2025 is projected to be $0.90 to $1.30.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2024
-0.9%
Avg return
Earnings day
-0.7%
Avg return
5 days after
-2.1%
Avg return
30 days after
41%
28 / 68 earnings
Positive
+28.3%
Q1 2020
Best reaction
-20.5%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.3% | -10.3% | -23.4% | |
| Q4 2025 | -18.1% | -16.7% | -29.8% | |
| Q3 2025 | -15.9% | -11.4% | -7.8% | |
| Q1 2025 | +11.2% | +18.8% | +28.7% | |
| Q4 2024 | +17.8% | +22.0% | +26.5% | |
| Q3 2024 | +1.1% | +11.6% | +15.7% | |
| Q2 2024 | -4.0% | -9.9% | -23.7% | |
| Q1 2024 | +4.3% | +10.3% | +8.1% | |
| Q4 2023 | -20.5% | -21.3% | -23.8% | |
| Q3 2023 | -11.2% | -8.6% | -7.5% | |
| Q2 2023 | -6.5% | -10.7% | -18.7% | |
| Q1 2023 | -3.7% | -4.2% | -13.1% | |
| Q4 2022 | +0.3% | +1.0% | -11.8% | |
| Q3 2022 | -18.8% | -9.4% | +7.7% | |
| Q2 2022 | -3.4% | -3.8% | -10.3% | |
| Q1 2022 | -2.8% | +0.4% | +5.2% | |
| Q4 2021 | +10.8% | +7.9% | -4.3% | |
| Q3 2021 | +6.1% | +8.9% | +10.5% | |
| Q2 2021 | +0.9% | -0.6% | -7.0% | |
| Q1 2021 | +11.7% | +13.5% | +17.0% | |
| Q4 2020 | -13.0% | -20.8% | -14.9% | |
| Q3 2020 | +3.9% | -10.3% | +0.9% | |
| Q2 2020 | +2.3% | +3.3% | +3.1% | |
| Q1 2020 | +28.3% | +24.9% | +44.6% | |
| Q4 2019 | -13.4% | -12.0% | -43.6% | |
| Q3 2019 | -15.3% | -11.5% | -19.2% | |
| Q2 2019 | +5.8% | +6.6% | +11.9% | |
| Q1 2019 | +26.9% | +15.5% | -4.9% | |
| Q4 2018 | -7.4% | +1.4% | -9.7% | |
| Q3 2018 | -13.4% | -10.5% | -12.1% | |
| Q2 2018 | +15.7% | +12.8% | +8.9% | |
| Q1 2018 | -1.1% | +1.8% | +11.8% | |
| Q4 2017 | -1.6% | +1.7% | +5.8% | |
| Q3 2017 | -4.3% | -5.4% | +4.3% | |
| Q2 2017 | -2.9% | -2.3% | -2.1% | |
| Q1 2017 | -2.5% | +1.5% | +1.7% | |
| Q4 2016 | -12.3% | -12.6% | -4.6% | |
| Q3 2016 | -8.7% | -8.2% | -14.0% | |
| Q2 2016 | +12.2% | +10.8% | +11.1% | |
| Q1 2016 | +3.2% | — | — | |
| Q4 2015 | -11.3% | — | — | |
| Q3 2015 | +4.5% | — | — | |
| Q2 2015 | +16.2% | — | — | |
| Q1 2015 | -5.0% | — | — | |
| Q4 2014 | +18.4% | — | — | |
| Q3 2014 | -19.6% | — | — | |
| Q2 2014 | -17.4% | — | — | |
| Q1 2014 | -10.9% | — | — | |
| Q4 2013 | -5.8% | — | — | |
| Q3 2013 | +8.6% | — | — | |
| Q2 2013 | +5.3% | — | — | |
| Q1 2013 | +5.0% | — | — | |
| Q4 2012 | -0.7% | — | — | |
| Q3 2012 | +16.7% | — | — | |
| Q2 2012 | +15.9% | — | — | |
| Q1 2012 | -12.8% | — | — | |
| Q4 2011 | -0.1% | — | — | |
| Q3 2011 | -3.9% | — | — | |
| Q2 2011 | -4.0% | — | — | |
| Q1 2010 | +1.6% | — | — | |
| Q1 2011 | +1.6% | — | — | |
| Q4 2008 | -2.0% | — | — | |
| Q4 2010 | -2.0% | — | — | |
| Q3 2010 | -2.1% | — | — | |
| Q3 2009 | -2.1% | — | — | |
| Q4 2009 | -6.1% | — | — | |
| Q2 2010 | -6.1% | — | — | |
| Q2 2009 | -6.1% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro